Viking Therapeutics - Articles and news items

Viking submits IND for VK2809 in hypercholesterolemia

Industry news / 18 November 2015 / Victoria White

VK2809 is a novel, orally available small molecule thyroid receptor agonist that possesses selectivity for liver tissue as well as the beta receptor subtype…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+